SGLT2: new approaches to combination therapy of type 2 diabetes mellitus

Abstract

Despite the emergence of new antidiabetic drugs, diabetes type 2 treatment remains a relevant issue. In order to standardize and optimize medical care to patients with diabetes, global and national algorithms for type 2 diabetes treatment were developed. [1, 2] The current algorithms focus on an individual approach, safety and effectiveness of treatment. A balance should be maintained between achieving optimal glycemic control and safety of therapy.

Keywords

• сахарный диабет 2-го типа
• комбинированная терапия
• инсулинорезистентность
• дисфункция бета-клеток
• метформин
• ингибитор sglt2
• дапаглифлозин
• type 2 diabetes
• combination therapy
• insulin resistance
• beta cell dysfunction
• metformin
• sglt2 inhibitor
• dap